Traders Buy High Volume of Tilray Brands Call Options (NASDAQ:TLRY)

Tilray Brands, Inc. (NASDAQ:TLRY) was the recipient of unusually large options trading activity on Wednesday. Traders bought 45,077 call options on the stock. This is an increase of 89% compared to the average volume of 23,817 call options.

Tilray Brands Stock Up 14.2%

Shares of NASDAQ TLRY opened at $7.87 on Thursday. The company has a quick ratio of 1.66, a current ratio of 2.79 and a debt-to-equity ratio of 0.19. Tilray Brands has a 52 week low of $3.51 and a 52 week high of $23.20. The firm’s fifty day moving average is $7.04 and its 200 day moving average is $9.53. The company has a market cap of $917.25 million, a price-to-earnings ratio of -0.58 and a beta of 2.00.

Tilray Brands (NASDAQ:TLRY) last issued its earnings results on Wednesday, April 1st. The company reported ($0.24) EPS for the quarter, missing the consensus estimate of ($0.14) by ($0.10). The firm had revenue of $206.73 million during the quarter, compared to analysts’ expectations of $201.35 million. Tilray Brands had a negative return on equity of 3.31% and a negative net margin of 156.51%.During the same period in the previous year, the firm earned ($0.87) earnings per share. On average, equities research analysts expect that Tilray Brands will post -0.55 earnings per share for the current year.

Trending Headlines about Tilray Brands

Here are the key news stories impacting Tilray Brands this week:

• Positive Sentiment: Reports the U.S. Justice Department will loosen cannabis restrictions sparked a sector-wide rally that lifted Tilray shares as investors price in a regulatory catalyst that would expand U.S. market opportunity and margin potential. Curaleaf and More Cannabis Stocks Soar. A Regulatory Breakthrough Is Coming.
• Positive Sentiment: Political momentum also surfaced after reports that former President Trump urged rapid reclassification of cannabis, reinforcing the regulatory narrative and prompting short-term buying and bullish options positioning. Tilray Stock Pops on New Trump-Driven Cannabis Hopes. Should You Chase the Rally?
• Positive Sentiment: Technical and research commentary points to a recovery setup: market write-ups highlight an early breakout and momentum that could carry TLRY higher if regulatory progress continues. Tilray Brands (TLRY) Price Forecast: Cannabis Rescheduling Fuels Recovery
• Positive Sentiment: Unusually large options activity: ~45,077 call contracts were bought (about +89% vs. typical daily call volume), indicating speculative bullish bets that can amplify upside moves in the underlying stock.
• Positive Sentiment: Analyst optimism: Roth Capital published a bullish note suggesting Tilray could rally >40% over 12 months based on improving fundamentals and the regulatory outlook, which can attract momentum and retail interest. 1 Wall Street Analyst Says Tilray Stock Could Jump Over 40%. Should You Believe It?
• Neutral Sentiment: Trading was briefly halted on a LULD (Limit Up/Limit Down) pause around 11:49 AM — a mechanical volatility control that indicates rapid price movement but doesn’t change the underlying drivers. (No external link provided.)
• Negative Sentiment: Insider selling: Director David G. Hopkinson sold 33,556 shares at an average $6.94 on April 21. Insider sales can be interpreted by some investors as a cautionary signal, even though they may be routine or pre-planned. Form 4 — David G. Hopkinson Sale

Insider Activity at Tilray Brands

In other Tilray Brands news, Director David G. Hopkinson sold 33,556 shares of Tilray Brands stock in a transaction that occurred on Tuesday, April 21st. The shares were sold at an average price of $6.94, for a total transaction of $232,878.64. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Company insiders own 0.84% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in TLRY. Tidal Investments LLC increased its position in Tilray Brands by 15.0% during the 2nd quarter. Tidal Investments LLC now owns 28,971,835 shares of the company’s stock valued at $12,006,000 after purchasing an additional 3,776,410 shares during the period. Millennium Management LLC increased its position in Tilray Brands by 281.0% during the 3rd quarter. Millennium Management LLC now owns 4,942,319 shares of the company’s stock valued at $8,550,000 after purchasing an additional 3,645,060 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new position in Tilray Brands during the 3rd quarter valued at $5,813,000. Ausdal Financial Partners Inc. purchased a new position in Tilray Brands during the 2nd quarter valued at $939,000. Finally, Scientech Research LLC purchased a new position in Tilray Brands during the 3rd quarter valued at $1,748,000. 9.35% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research analysts recently commented on TLRY shares. Roth Mkm raised shares of Tilray Brands from a “neutral” rating to a “buy” rating and set a $10.00 target price on the stock in a research note on Thursday, April 2nd. TD Cowen decreased their target price on shares of Tilray Brands from $10.00 to $7.00 and set a “buy” rating on the stock in a research note on Monday, March 30th. Canaccord Genuity Group started coverage on shares of Tilray Brands in a research note on Tuesday, January 27th. They issued a “hold” rating on the stock. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Tilray Brands in a research note on Wednesday, January 21st. Finally, ATB Cormark Capital Markets decreased their target price on shares of Tilray Brands from $9.50 to $9.00 and set a “sector perform” rating on the stock in a research note on Thursday, April 2nd. Three research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Tilray Brands has an average rating of “Hold” and an average price target of $11.50.

About Tilray Brands

Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.

Tilray’s product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.